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Background: We surveyed a population of injection drug users (IDUs) frequenting the mobile Baltimore City
Needle Exchange Program (BNEP) to investigate self-care factors associated with chronic wounds, a significant
cause of morbidity especially among older IDUs.
Methods: Participants ≥18 years old completed a survey regarding chronic wounds (duration ≥8 weeks), injection
and hygiene practices. Study staff visually verified the presence of wounds. Participants were categorized into four
groups by age and wound status. Factors associated with the presence of chronic wounds in participants ≥45 years
were analyzed using logistic regression.
Results: Of the 152 participants, 19.7% had a chronic wound. Of those with chronic wounds, 18 were ≥45 years
old (60.0%). Individuals ≥45 years old with chronic wounds were more likely to be enrolled in a drug treatment
program (Odds ratio (OR) 3.4, 95% Confidence interval (CI) 1.0–10.8) and less likely to use cigarette filters when
drawing up prepared drug (OR 0.2, 95% CI 0.03–0.7) compared to the same age group without chronic wounds.
Compared to individuals <45 years old without chronic wounds, individuals ≥45 with a chronic wound were more
likely to report cleaning reused needles with bleach (OR 10.7, 95% CI 1.2–93.9) and to use the clinic, rather than an
emergency room, as a primary source of medical care (OR 3.4, 95% CI 1.1–10.4).
Conclusions: Older IDUs with chronic wounds have different, and perhaps less risky, injection and hygiene behaviors
than their peers and younger IDUs without wounds in Baltimore City. Because of these differences, older IDUs with
wounds may be more receptive to community-based healthcare and substance abuse treatment messages.
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Older injection drug users (IDUs) are a growing sub-
group of active IDUs and IDUs seeking treatment [1-5].
It is estimated that the number of adults 50 years or
older with substance use problems will double from an
annual average of 2.8 million (2002–06) to 5.7 million by
2020 [6]. Age-associated health complications and on-
going chronic drug use may further intensify the social
marginalization of older IDUs, which may diminish qual-
ity of life, access to health care and social productivity
[7,8]. Furthermore, injection drug use has been associated* Correspondence: kej1229@gmail.com
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unless otherwise stated.with accelerated biologic aging [9,10] and the premature
onset of health conditions normally associated with aging
[3,11,12]. Due to these life course differences and evidence
that IDUs have higher overall mortality rates, older IDUs
are of growing interest to public health researchers and
are typically defined as individuals older than 40–50 years
[13,14].
Overall, older IDUs report impaired mental and physical
health and functioning compared to age- and gender-
matched population standards [15,16]. Older IDUs often
self-reported health conditions such as deep vein throm-
bosis, skin ulcers, respiratory problems, diabetes, hyper-
tension, hepatitis, and liver cirrhosis [8,15]. Studies on
venous damage and chronic venous insufficiency (CVI) intd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Smith et al. Harm Reduction Journal 2014, 11:28 Page 2 of 9
http://www.harmreductionjournal.com/content/11/1/28IDUs revealed that CVI develops prematurely in IDUs
[11,12].
Certain risky injection drug use behaviors such as
sharing needles, subcutaneous injection (skin-popping),
injecting a mixture of heroin and cocaine (speedballing),
using cigarette filters to draw up prepared drug, and
injection under unhygienic conditions, have been linked
to adverse outcomes such as abscesses, skin and soft
tissue infections, injection site ulcers, and endocarditis
[17-25]. Local and national public health authorities
have implemented harm reduction measures to raise
awareness and to educate IDUs regarding these risky
behaviors. However, efforts have not been focused on rais-
ing awareness of the long-term consequences of injection-
related venous damage among IDUs, which can lead to
CVI and lower extremity ulcers. The effectiveness of
these programs may also be attenuated by an individual’s
severity of addiction, socio-cultural environment and prior
exposure to harm reduction messages [5].
Some studies have determined that older IDUs who
started injecting at a young age, as opposed to later in
adulthood, were more likely to have high-risk injection
practices including sharing of injection equipment and
more frequent injection [26,27]. In addition, the existing
literature regarding the aging IDU population focuses
on general physical and mental health conditions or
injection-related behaviors [13,15,16,26-29]. The injec-
tion behaviors and socio-demographic characteristics of
IDUs living with chronic wounds have not been well
explored, even though chronic wounds are a significant
health concern among older active or former IDUs.
We examined the prevalence of chronic wounds and
associated injection-related behaviors among an IDU
population accessing needle exchange services from the
Baltimore City mobile Needle Exchange Program (BNEP),
which has been in operation since 1994 [30]. We were
interested specifically in determining whether there
were distinctions between the demographics and behav-
iors of older IDUs living with chronic wounds as com-
pared to their peers and younger IDUs. An improved
understanding of the behaviors of older IDUs may help
inform prevention strategies and both skin- and drug-
related treatment efforts for individuals living with
chronic wounds.
Methods
We conducted a cross-sectional study among active IDU
participants of the BNEP, age ≥18 years, regardless of
wound status. Data collection occurred between May
2012 and November 2013 and was conducted at five
different exchange sites, though most participants were
from Site A and Site B, which were 1.9 miles apart and
demographically distinct. Site A is frequented primarily
by African Americans and Site B is frequented primarilyby Caucasians. Site C was near several local exotic dance
clubs and was geographically separate from Sites A and B.
All participants provided written, informed consent
and completed a paper-administered survey including
questions addressing demographics, injection behaviors,
pre-injection skin care, wound history, wound care, and
general medical history. Surveys required approximately
20 minutes and upon completion, participants were
given a $10 gift card for local businesses. Chronic wounds
were defined as open areas on the skin that had been
present and non-healing for ≥8 weeks. Study team mem-
bers visually verified the presence of chronic wounds at
the time of the survey. This study was approved by the
Johns Hopkins Medicine Institutional Review Board.
Participants were stratified into four groups by reported
age (<45 years or ≥45 years) and wound status (presenting
with a current chronic wound or without a current chronic
wound). The primary outcome was considered the presence
of a chronic wound among participants ≥45 years. This
outcome was independently compared to three distinct
reference groups: 1) participants < 45 years without chronic
wounds; 2) participants ≥45 years without chronic wounds;
3) participants < 45 years with chronic wounds.
All variables were categorical except for age and num-
ber of times a needle was used, which were continuous
variables. Predictor variables associated with the primary
outcome group were analyzed using univariate and multi-
variate logistic regression. Odds ratios predicting risk of
outcomes of interest with 95% confidence intervals were
assessed. T-tests were used to compare means and/or
proportions. P values ≤ 0.05 were considered statistically
significant. Statistical analysis was performed using Stata
12 (StataCorp, College Station, TX).
Results
A total of 152 individuals were surveyed. The overall
prevalence of chronic wounds was 19.7% (n/N = 30/152).
Of the 152 individuals, 73 were younger than 45 years
(48.0%) and 79 were aged 45 years or older (52.0%). Of
those with chronic wounds, 12 were in individuals younger
than 45 years (40.0%) and 18 were in individual aged
45 years or older (60.0%) (p = 0.121). We focused our
analysis on the latter subgroup of participants: IDUs who
were 45 years of age or older with at least one current
chronic wound. This group accounted for 11.8% of all
study participants (18/152).
Within the particular subgroup of interest (IDUs
age ≥45 years with chronic wound(s)), the median age
was 55 years with an interquartile range (IQR) of 46–58.
The participants were primarily male (61.1%), African
American (72.2%), reported having stable housing (94.4%),
and had a self-reported HIV prevalence rate of 27.8%
(5/18). They reported long histories with injection drug
use, most having injected for greater than 15 years
Table 1 Socio-demographic, medical and injection behaviors by age and chronic wound status †
All participants Outcome group ≥45 years,
with chronic wound
Reference group
#1 <45 years, no
chronic wound
Reference group
#2 ≥45 years, no
chronic wound
Reference group
#3 < 45 years, with
chronic wound






N = 152 N = 18 N = 61 N = 61 N = 12
All participants (N = 152) 152 (100.0) 18 (11.8) 61 (40.1) … 61 (40.1) … 12 (7.9) …
Ageb,c 45; (35–52) 55; (46–58) 33; (28–39) <0.001* 52; (49–57) 0.579 40; (35–42) <0.001*
Gender
Male 96 (63.2) 11 (61.1) 31 (50.8) 0.442 48 (78.7) 0.131 6 (50.0) 0.548
Female 56 (36.8) 7 (38.9) 30 (49.2) 0.442 13 (21.3) 0.131 6 (50.0) 0.548
Race
Caucasian 75 (49.3) 4 (22.2) 47 (77.1) <0.001* 16 (26.2) 0.701 8 (66.7) 0.015*
African American 68 (44.7) 13 (72.2) 9 (14.8) <0.001* 44 (72.1) 0.926 2 (16.7) 0.003*
Native American 4 (2.6) 1 (5.6) 1 (1.6) 0.379 0 (0.0) 0.063 2 (16.7) 0.322
Other or Multipled 5 (3.3) 0 (0.0) 4 (6.6) 0.263 1 (1.6) 0.589 0 (0.0) …
Housinge
Stable 113 (74.3) 17 (94.4) 41 (67.2) 0.022* 47 (77.1) 0.100 8 (66.7) 0.046*
Unstable 39 (25.7) 1 (5.6) 20 (32.8) 0.022* 14 (23.0) 0.100 4 (33.3) 0.046*
Exchange site
Site A 54 (35.5) 9 (50.0) 10 (16.4) 0.003* 34 (55.7) 0.670 1 (8.3) 0.018*
Site B 72 (47.4) 5 (27.8) 40 (65.6) 0.004* 18 (29.5) 0.889 9 (75.0) 0.011*
Site C 5 (3.3) 0 (0.0) 4 (6.6) 0.263 0 (0.0) – 1 (8.3) 0.214
Other 21 (13.8) 4 (22.2) 7 (11.5) 0.249 9 (14.8) 0.457 1 (8.3) 0.316
Jail/prison - past 6 months 45 (29.6) 1 (5.6) 28 (45.9) 0.002* 12 (19.7) 0.157 4 (33.3) 0.046*
Years injecting drugs
≤2 15 (9.9) 0 (0.0) 12 (19.7) 0.041* 2 (3.3) 0.435 1 (8.3) 0.214
3 – 8 25 (16.4) 0 (0.0) 18 (29.5) 0.009* 5 (8.2) 0.209 2 (16.7) 0.073
9 – 14 20 (13.2) 1 (5.6) 12 (19.7) 0.157 5 (8.2) 0.715 2 (16.7) 0.322
≥15 92 (60.5) 17 (94.4) 19 (31.2) <0.001* 49 (80.3) 0.157 7 (58.3) 0.016*
Injection site location
Arm 92 (60.5) 7 (38.9) 38 (62.3) 0.078 39 (63.9) 0.059 8 (66.7) 0.136
Leg 37 (24.3) 11 (61.1) 8 (13.1) <0.001* 16 (26.2) 0.006* 2 (16.7) 0.016*
Neck 17 (11.2) 4 (22.2) 10 (16.4) 0.571 2 (3.3) 0.008* 1 (8.3) 0.317
Drug treatment programf 36 (23.7) 8 (53.3) 12 (20.7) 0.012* 15 (25.4) 0.037* 1 (11.1) 0.039*
Using cigarette filterg 65 (42.8) 2 (11.8) 31 (51.7) 0.003* 28 (46.7) 0.009* 4 (40.0) 0.089
Using needles (# of times)h 3; 1 – 4 1; 1 – 3 3; 2 – 7 <0.001* 2; 1 – 3 0.021* 3; 2 – 3 0.112
Clean needles upon reusei
Water 56 (50.5) 1 (12.5) 29 (60.4) 0.012* 23 (51.1) 0.043* 3 (30.0) 0.375
Bleach 55 (49.5) 7 (87.5) 19 (39.6) 0.012* 22 (48.9) 0.043* 7 (70.0) 0.375
Cleaning injection sitej
Do not clean 35 (23.0) 4 (22.2) 13 (21.3) 0.935 12 (19.7) 0.817 6 (50.0) 0.114
Water 12 (7.9) 0 (0.0) 4 (6.6) 0.263 7 (11.5) 0.132 1 (8.3) 0.214
Soap/water 14 (9.2) 0 (0.0) 9 (14.8) 0.083 4 (6.6) 0.263 1 (8.3) 0.214
Alcohol 83 (54.6) 13 (72.2) 33 (54.1) 0.171 34 (55.7) 0.210 3 (25.0) 0.011*
Multiple or other 8 (5.3) 1 (5.6) 2 (3.3) 0.655 4 (6.6) 0.879 1 (8.3) 0.772
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Table 1 Socio-demographic, medical and injection behaviors by age and chronic wound status † (Continued)
Medical care provider
Clinic 48 (31.6) 9 (50.0) 14 (23.0) 0.027* 23 (37.7) 0.350 2 (16.7) 0.064
Private doctor 14 (9.2) 1 (5.6) 5 (8.2) 0.715 6 (9.8) 0.581 2 (16.7) 0.322
Emergency room 85 (55.9) 8 (44.4) 42 (68.9) 0.058 28 (45.9) 0.911 7 (58.3) 0.456
Other 5 (3.3) 0 (0.0) 0 (0.0) – 4 (6.6) 0.263 1 (8.3) 0.214
† All numbers have been rounded to nearest decimal place.
ap values refer to the comparison between the Reference group and the Outcome Group. p value for “Age” was obtained using two-group mean comparison




eUnstable includes living in a shelter, on the streets, in an abandoned unit, no set place, or multiple. Stable housing includes living in an owned/rented house,
subsidized housing, with a friend, other (e.g. transitional house).
fParticipant in a drug treatment program; Denominator changes where responses were missing: All: N = 152; Outcome group: N = 15; Reference group #1: N = 58;
Reference group #2: 59; Reference group #3: N = 9.
gUsing cigarette filters to draw up prepared drug; Denominator changes where responses were missing: All: N = 152; Outcome group: N = 17; Reference group #1:
N = 60; Reference group #2: 60; Reference group #3: N = 10.
hDenominator changes where responses were missing: All: N = 150; Outcome group: N = 17; Reference group #1: N = 61; Reference group #2: 60; Reference group
#3: N = 12.
iIncludes only participants who reported reusing needles. All: N = 111; Outcome group: N = 8; Reference group #1: N = 48; Reference group #2: 45; Reference group
#3: N = 10.
jMost frequent method of cleaning injection site before injection; “Other” includes bleach, saliva, baby wipe, multiple agents.
*p ≤ 0.05.
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included daily heroin injection (72.2%), daily speedball
injection (55.6%), leg injection (61.1%) and cleaning the
injection site with alcohol before injecting (72.2%). Of the
nine participants who reported reusing their needles
(9/18, 50.0%), seven of eight reported cleaning their
needles with bleach prior to reuse (87.5%). Older IDUs with
chronic wounds also reused their needles less frequently
compared to their peers without wounds (p = 0.021) and
compared to younger IDUs without wounds (p < 0.001).
See Table 1 for additional information on demographics, in-
jection practices and medical history for all participants,
participants in the outcome group (IDUs age ≥45 years
with chronic wound(s)), and participants in the three refer-
ence groups.
Older IDUs with chronic wounds compared to younger
IDUs without wounds
Compared to individuals younger than 45 years who did
not have chronic wounds, the univariate analysis indicated
that participants older than 45 years old with chronic
wounds were more likely to be African American com-
pared to Caucasian (Odds ratio (OR) 17.0, 95% Confidence
interval (CI) 4.5 – 64.1, p < 0.001), to have stable housing
(OR 8.3, 95% CI 1.0–66.8, p = 0.047), to visit a clinic as their
primary source of medical care rather than an emergency
room (OR 3.4, 95% CI 1.1–10.4, p = 0.035), and to frequent
BNEP site A versus Site B (OR 7.2, 2.0–26.3, p = 0.003)
(Table 2A). They were also more likely to have injected
drugs for 15 or more years (OR 10.7, 95% CI 1.3–91.5,
p = 0.030), to be participating in a drug treatment program
(OR 4.4, 95% CI 1.3–14.5, p = 0.016), to inject speedball
everyday (OR 4.2, 95% CI 1.1–15.7, p = 0.035), to injectinto the leg (OR 10.4, 95% CI 3.1–34.7, p = <0.001) and to
clean needles with bleach upon reuse (OR 10.7, 95% CI
1.2–93.9, p = 0.033). Additionally, they were less likely to
have been in jail or prison for more than 24 hours during
the past 6 months (OR 0.07, 95% CI 0.009–0.6, p = 0.012),
and also less likely to use cigarette filters to draw up pre-
pared drug (OR 0.1, 95% CI 0.03–0.6, p = 0.009).
In the multivariate model, older individuals with wounds
were more likely to be African American (Adjusted odds
ratio (AOR) 16.3, 95% CI 1.4–190.3, p = 0.026) and inject
into the leg (AOR 9.9, 95% CI 1.3–73.1, p = 0.024), and they
were less likely to use cigarette filters (AOR 0.06, 95% CI
0.004–0.9, p = 0.039) (Table 2B).
Older IDUs with chronic wounds compared to similar-aged
peers without wounds
Among participants 45 years or older, those with a chronic
wound were more likely to be in a drug treatment pro-
gram (OR 3.4, 95% CI 1.0–10.8, p = 0.043), and to inject
into the leg (OR 4.4, 95% CI 1.5–13.4, p = 0.008) or neck
(OR 8.4, 95% CI 1.4–50.7, p = 0.020), compared to the
same age group without chronic wounds (Table 3A). In
the multivariable model, older individuals with chronic
wounds remained less likely to use cigarette filters when
drawing up prepared drug into the syringe (AOR 0.1, 95%
CI 0.01–0.9, p = 0.044) (Table 3B).
Older IDUs with chronic wounds compared to younger
IDUs with wounds
Among participants with chronic wounds, those 45 years
or older were more likely to be African American (OR
13.0, 95% CI 1.9–88.0, p = 0.009), to exchange needles at
Site A compared to Site B (OR 16.2, 95% CI 1.6–167.7,
Table 2 Group #1: Older IDUs with chronic wounds compared to younger IDUs without wounds
A. univariate (N = 79) B. multivariatea (N = 71)
OR 95% CI p OR 95% CI p
Race
Caucasian Ref Ref
African American 17.0 4.5 – 64.1 <0.001* 16.3 1.4 – 190.3 0.026*




Stable 8.3 1.0 – 66.8 0.047* …d
Medical Care
Emergency room Ref
Clinic 3.4 1.1 – 10.4 0.035* …d
Private doctor 1.1 0.1 – 10.2 0.996
Other …b
Exchange site (N = 29)
Site A Ref Ref
Site B 7.2 2.0 – 26.3 0.003* 1.5 0.2 – 12.0 0.719
Site C 4.6 1.0 – 21.3 0.053* 17.8 1.2 – 254.5 0.034*
Time injecting drugs (years)
9 – 14 Ref
≥15 10.7 1.3 – 91.5 0.030* …d
Participating in drug treatment program
No Ref
Yes 4.4 1.3 – 14.5 0.016* …d
Speedball
Never Ref
Occasionally 1.2 0.3 – 5.3 0.820 …d
Everyday 4.2 1.1 – 15.7 0.035*
Injecting into leg
No Ref Ref
Yes 10.4 3.1 – 34.7 <0.001* 9.9 1.3 – 73.1 0.024*
Skin-popping
No Ref
Yes 4.4 1.0 – 19.9 0.055 …d
Cleaning needle with bleach upon reuse
Water Ref
Bleach 10.7 1.2 – 93.9 0.033* …d
Jail/Prison during last 6 months
No Ref
Yes 0.07 0.009 – 0.6 0.012* …d
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Table 2 Group #1: Older IDUs with chronic wounds compared to younger IDUs without wounds (Continued)
Cigarette filters to draw up drug
No Ref Ref
Yes 0.1 0.03 – 0.6 0.009* 0.06 0.004 – 0.9 0.039*
Abbreviations: IDUs injection drug users, OR odds ratio, CI confidence interval.
aVariables with at least one category with p ≤ 0.010 at the univariate level were included in the multivariate model.
bInsufficient observations for both univariate and multivariate logistic regression.
cUnstable includes living in a shelter, on the streets, in an abandoned unit, no set place, or multiple. Stable housing includes living in an owned/rented house,
subsidized housing, with a friend, other (e.g. transitional house).
dNot included in multivariate model.
*p ≤ 0.05.
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p = 0.024), and to clean the injection site with alcohol
before injection (OR 6.5, 95% CI 1.1–38.6, p= 0.040) when
compared to younger IDUs with chronic wounds (Table 4A).
In the multivariate model, leg injection was more common
among older individuals with chronic wounds (AOR 31.3,
95% CI 1.1–873.6, p= 0.043) (Table 4B).
Discussion
The high prevalence of chronic wounds in our community-
recruited IDU study population (19.7%) and the dispropor-
tionate overrepresentation of older IDUs with chronic
wounds (60%) suggests the need for focused interventions
to improve awareness of injection-related venous damage
and chronic wounds in IDUs to better prevent and treat
this condition.
Upon comparing older IDUs with chronic wounds to
their same-aged peers without chronic wounds and to
younger IDUs with and without wounds, this group ofTable 3 Group #2: Older IDUs with chronic wounds compared
A. univariate (
OR 95% CI
Trading sex for money
No Ref
Yes 3.3 1.1 – 10.0
Participating in drug treatment program
No Ref
Yes 3.4 1.0 – 10.8
Injecting into leg
No Ref
Yes 4.4 1.5 – 13.4
Injecting into neck
No Ref
Yes 8.4 1.4 – 50.7
Using cigarette filters to draw up drug
No Ref
Yes 0.2 0.03 – 0.7
Abbreviations: IDUs injection drug users, OR odds ratio, CI confidence interval.
aVariables with at least one category with p ≤ 0.050 at the univariate level were incl
*p ≤ 0.05.older individuals with wounds appeared to engage in
behaviors that were more consistent with self-care habits
and less-risky injection practices. For example, they were
more likely to have stable housing, use a clinic rather
than an emergency room as the primary source of medical
care, participate in a drug treatment program, clean nee-
dles with bleach, and clean their injection site with alcohol
before injection. They were also less likely to have been
recently in jail or prison, or to have used cigarette filters
to draw up prepared drug. Use of cigarette filters, rather
than needle exchange-distributed packed cotton filters, is
considered riskier behavior and generally discouraged by
harm reduction advocates because it is less effective at
filtering particles out of the drug and can be associated
with endocarditis or phlebitis [23,31]. It is possible that
older IDUs with wounds are in a different stage of life, as
they have survived for many years with substance abuse
issues and have perhaps learned to cope with their
substance abuse and chronic health conditions betterto older IDUs without wounds
N = 79) B. multivariatea (N = 72)
p OR 95% CI p
Ref
0.039* 2.3 0.4 – 13.9 0.346
Ref
0.043* 3.2 0.8 – 12.9 0.098
Ref
0.008* 3.2 0.7 – 13.4 0.120
Ref
0.020* 4.9 0.4 – 58.3 0.212
Ref
0.018* 0.1 0.01 – 0.9 0.044*
uded in the multivariate model.
Table 4 Group #3: Older IDUs with chronic wounds compared to younger IDUs with wounds
A. univariate (N = 30) B. multivariatea (N = 21)
OR 95% CI p OR 95% CI p
Race
Caucasian Ref Ref
African American 13.0 1.9 – 88.0 0.009* 4.3 0.06 – 290.1 0.502
Native American 1.0 0.07 – 14.6 1.000 0.1 0.001 – 12.7 0.387
Other …b
Exchange site (N = 29)
Site A Ref Ref
Site B 16.2 1.6 – 167.7 0.020* 2.0 0.03 – 146.2 0.751
Site C 7.2 0.6 – 83.3 0.114 …b
Injecting into leg
No Ref Ref
Yes 7.9 1.3 – 47.0 0.024* 31.3 1.1 – 873.6 0.043*
Cleaning injection site before injection (N = 26) c
Do not clean Ref Ref
Alcohol 6.5 1.1 – 38.6 0.040* 13.5 0.5 – 390.6 0.130
Abbreviations: OR odds ratio, CI confidence interval.
aVariables with at least one category with p ≤ 0.050 at the univariate level were included in the multivariate model.
bInsufficient observations for logistic regression
cOther categories within this variable were dropped in univariate and multivariate analysis due to insufficient observations. Dropped variables included water,
soap/water, multiple or other.
*p ≤ 0.05.
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differences in behaviors surrounding injection and cleanli-
ness are a result of living with a chronic wound, maturing
as an injection drug user and/or the internalization of the
syringe exchange program’s ongoing harm reduction
messages and education.
Older IDUs with wounds were more likely to be African
American even after adjusting for exchange site. In
contrast, younger IDUs were more likely to be Caucasian.
These findings may be a reflection of the drug use
patterns in Baltimore City and at the BNEP sites that
were surveyed. This suggests that there are racial and/
or socio-cultural differences among younger Caucasian
IDUs that may lend preference for certain, and perhaps
riskier, injection-related and other destabilizing behaviors
that may lead to increased rates of homelessness and
incarceration, among other factors, that we observed in
this analysis. Understanding these differences within local
subgroups of an IDU population may facilitate more
targeted harm reduction efforts.
Other findings from this study are consistent with a
population engaged in long-term injection drug use,
which can lead to venous scarring and venous disease.
As IDUs mature in their injection drug use habits, there
may be increasing reliance on injecting into veins in
other locations such as the leg or neck, as we observed
among the older IDUs with wounds. Chronic wounds
appear to be associated with prolonged drug use, evenamong the younger IDUs, as the majority of younger IDUs
with chronic wounds had also been injecting for at least
15 years. Injecting into the leg together with prolonged in-
jection drug use, resultant venous damage and physiologic
aging of the veins, likely puts older IDUs at heightened
risk for both CVI and lower extremity ulcers [32].
Our study had limitations. Participants were active mem-
bers of the BNEP, and therefore they may report different
injection and skin care practices than IDUs not accessing
community-based harm reduction services and education.
The survey also relied upon self-reported data. Additionally,
there were limitations associated with the small sample size
of individuals with chronic wounds, however the overall
cohort size and survey design was sufficient to characterize
some behaviors as truly distinct in the population with
chronic wounds. Despite these potential limitations, we
report for the first time self-care behaviors among older
IDUs living with chronic wounds in a mobile metropolitan
needle exchange program in Baltimore City.
Conclusions
Our findings suggest that older IDUs with chronic wounds
have different, and perhaps less risky, injection and hygiene
practices than their peers and younger IDUs without
wounds. Moreover, older IDUs with chronic wounds may
represent a different demographic among those using illicit
substances and a distinct IDU subgroup that may be more
receptive to local healthcare and/or substance abuse
Smith et al. Harm Reduction Journal 2014, 11:28 Page 8 of 9
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likely to engage in meaningful relationships and thera-
peutic alliances with medical providers to address drug
use and/or health conditions previously neglected.
Future public health and harm reduction interventions to
raise awareness of the known associations between injec-
tion practices, venous damage, and chronic wounds among
IDUs who have recently initiated injecting and among IDUs
who have a prolonged injection history may represent
valuable measures to prevent long-term wound-associated
morbidity and disability. Harm reduction programs should
consider including such educational information and
referrals to local wound care centers in their regular
encounters with IDUs.
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